Separation of antiviral nucleoside phosphoramidate diastereomers by analytical supercritical fluid chromatography
暂无分享,去创建一个
Wei Chen | Zhuan Hong | H. Fang | Yu Fen Zhao | Ruizao Yi | Zhuan Hong
[1] Rimo Xi,et al. Enantiomeric separation of 1,4-dihydropyridines by liquid-phase microextraction with supercritical fluid chromatography , 2016 .
[2] A. Alwarthan,et al. Validated chiral high performance liquid chromatography separation method and simulation studies of dipeptides on amylose chiral column. , 2015, Journal of chromatography. A.
[3] K. Nakagawa,et al. Direct separation of the diastereomers of phosphatidylcholine hydroperoxide bearing 13-hydroperoxy-9Z,11E-octadecadienoic acid using chiral stationary phase high-performance liquid chromatography. , 2015, Journal of chromatography. A.
[4] W. Lindner,et al. Method development and optimization on cinchona and chiral sulfonic acid-based zwitterionic stationary phases for enantiomer separations of free amino acids by high-performance liquid chromatography. , 2014, Journal of chromatography. A.
[5] Eva Tesařová,et al. Supercritical fluid chromatography as a tool for enantioselective separation; a review. , 2014, Analytica Chimica Acta.
[6] Calum Morrison,et al. Pharmaceutical and forensic drug applications of chiral supercritical fluid chromatography , 2014 .
[7] Jimmy O. DaSilva,et al. Evaluation of non-conventional polar modifiers on immobilized chiral stationary phases for improved resolution of enantiomers by supercritical fluid chromatography. , 2014, Journal of chromatography. A.
[8] P. Xu,et al. Separation of d4T-P-N-PheOMe Diastereoisomers by Supercritical Fluid Chromatography , 2012 .
[9] J. Balzarini,et al. The cytostatic activity of NUC-3073, a phosphoramidate prodrug of 5-fluoro-2'-deoxyuridine, is independent of activation by thymidine kinase and insensitive to degradation by phosphorolytic enzymes. , 2011, Biochemical pharmacology.
[10] Yufen Zhao,et al. Fast separation of antiviral nucleoside phosphoramidate and H-phosphonate diastereoisomers by reversed-phase liquid chromatography. , 2011, Journal of chromatography. A.
[11] A. Brancale,et al. The application of phosphoramidate protide technology to acyclovir confers anti-HIV inhibition. , 2009, Journal of medicinal chemistry.
[12] S. Harper,et al. Phosphoramidate prodrugs of 2'-C-methylcytidine for therapy of hepatitis C virus infection. , 2009, Journal of medicinal chemistry.
[13] Qilong Ren,et al. Enantioseparation of paroxetine intermediate on an amylose-derived chiral stationary phase by supercritical fluid chromatography. , 2009, Journal of chromatography. A.
[14] H. Murakami. From Racemates to Single Enantiomers - Chiral Synthetic Drugs over the last 20 Years. , 2007, Topics in current chemistry.
[15] F. Uckun,et al. Protease-mediated enzymatic hydrolysis and activation of aryl phosphoramidate derivatives of stavudine. , 2005, European journal of medicinal chemistry.
[16] M. D. del Nozal,et al. Chiral separation of some triazole pesticides by supercritical fluid chromatography. , 2004, Journal of chromatography. A.
[17] M. Gumbleton,et al. Stereospecific chemical and enzymatic stability of phosphoramidate triester prodrugs of d4T in vitro. , 2004, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[18] P. Sandra,et al. Rapid method development for chiral separation in drug discovery using sample pooling and supercritical fluid chromatography-mass spectrometry. , 2003, Journal of chromatography. A.
[19] Jianxun Kang,et al. One-pot synthesis of hydrogen phosphonate derivatives of d4T and AZT. , 2002, Chemical communications.
[20] M. Garzotti,et al. Supercritical fluid chromatography coupled to electrospray mass spectrometry: a powerful tool for the analysis of chiral mixtures. , 2002, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[21] F. Uckun,et al. In vivo pharmacokinetics and metabolism of anti-human immunodeficiency virus agent D4T-5'-[p-bromophenyl methoxyalaninyl phosphate] (SAMPIDINE) in mice. , 2001, Drug metabolism and disposition: the biological fate of chemicals.
[22] A. Aubertin,et al. Synthesis and anti-HIV activity of some novel arylphosphate and H-phosphonate derivatives of 3'-azido-2',3'-dideoxythymidine and 2',3'-didehydro-2',3'-dideoxythymidine. , 1999, Antiviral research.
[23] E. De Clercq,et al. Aryl phosphoramidate derivatives of d4T have improved anti-HIV efficacy in tissue culture and may act by the generation of a novel intracellular metabolite. , 1996, Journal of medicinal chemistry.
[24] R. Schinazi,et al. Aromatic amino acid phosphoramidate di- and triesters of 3′-azido-3′-deoxythymidine (AZT) are non-toxic inhibitors of HIV-1 replication , 1995 .
[25] E. De Clercq,et al. Differential patterns of intracellular metabolism of 2',3'-didehydro-2',3'-dideoxythymidine and 3'-azido-2',3'-dideoxythymidine, two potent anti-human immunodeficiency virus compounds. , 1989, The Journal of biological chemistry.